COVID-19: A review and considerations for the resumption of activities in an IVF laboratory and clinic in Brazil.

Autor:	Ceschin I; Feliccità Instituto de Fertilidade - Curitiba, Paraná, Brasil.; Centro de Estudos sobre o Genoma Humano e Células-Tronco (CEGH-CEL), Departamento de Biologia Evolutiva, Instituto de Biociências - Universidade de São Paulo, São Paulo, Brasil., Ali T; Laboratório Igenomix - Laboratório de Genética e Medicina Reprodutiva - São Paulo, São Paulo, Brasil., Carvalho C; Laboratório Igenomix - Laboratório de Genética e Medicina Reprodutiva - São Paulo, São Paulo, Brasil., Uehara M; Laboratório Igenomix - Laboratório de Genética e Medicina Reprodutiva - São Paulo, São Paulo, Brasil., Motta P; Laboratório Igenomix - Laboratório de Genética e Medicina Reprodutiva - São Paulo, São Paulo, Brasil., Riboldi M; Laboratório Igenomix - Laboratório de Genética e Medicina Reprodutiva - São Paulo, São Paulo, Brasil.
Jazyk:	angličtina
Zdroj:	JBRA assisted reproduction [JBRA Assist Reprod] 2021 Apr 27; Vol. 25 (2), pp. 293-302. Date of Electronic Publication: 2021 Apr 27.
DOI:	10.5935/1518-0557.20200102
Abstrakt:	COVID-19 has caused radical effects on the daily lives of millions of people. The causal agent of the current pandemic is SARS-CoV-2, a virus that causes symptoms related to the respiratory system, leading to severe complications. In the in vitro fertilization (IVF) universe, there are several protocols for infection control and laboratory safety. Some professional associations have issued guidelines recommending measures involving patient flow and IVF practices. This study presents a review and considerations for the resumption of activities in IVF laboratories and clinics in Brazil during the COVID-19 pandemic, according to the guidelines and statements from professional organizations and societies in reproductive medicine.
Databáze:	MEDLINE
Externí odkaz: